On the HCPLive psoriatic arthritis page, resources on the topics of medical news and expert insight into PsA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on arthritis, and more.
April 26th 2024
Using a cut-off value of 7.1 kPA for liver stiffness, results of the transient elastography yielded 100% sensitivity and 68% specificity among this patient population.
New Promising Phase 3 Bimekizumab Data Among Patients with Psoriatic Arthritis
May 23rd 2022Data from 2 studies evaluating adults with active psoriatic arthritis were announced today in preparation for EULAR 2022. The different population groups who received treatment were biologic-naive patients and TNF-inadequate responders.
Q&A: Long-Term Safety of Ixekizumab Use in Patients With Psoriatic Arthritis
May 2nd 2022In this Q&A, Gerd R. Burmester, MD, discussed the findings of his study that evaluated the exposure to ixekizumab, outcomes and medical history of patients with active psoriatic arthritis (PsA) who experienced adverse events.
Poor Treatment Response Linked to Residual Disease in Patients with PsA
“Although the achievement of treatment targets has been associated with improved quality of life and slower disease progression, patients may still experience symptoms and a burden of disease,” investigators stated.
Joint, Musculoskeletal Pain Ranked Most Vexing Symptom in Patients With PsA
“Incorporating patient perspectives will not only help better tailor therapies in this heterogeneous population but also identify treatment targets that are relevant to the individual patients," investigators explained.